Maverick Novartis shaking up go-to-market strategy for new heart drug

Retrieved on: 2021-11-29 15:07:08

Tags for this article:

Health sciences

Health care

Health

PCSK9 inhibitors

Monoclonal antibodies

Pharmaceutical industry

Low-density lipoprotein

Click the tags to see associated articles and topics

Maverick Novartis shaking up go-to-market strategy for new heart drug. View article details on hiswai:

Excerpt

Novartis is tossing out the marketing playbook for the launch of cholesterol drug inclisiran, The Wall Street Journal reported last week. The strategy ...

Article found on: www.mmm-online.com

View Original Article